Gemina Laboratories Ratios and Metrics

Market cap in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 24, 2024	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Market Capitalization	34	41	45	27	-
Market Cap Growth	-8.48%	-8.48%	63.35%	-	-
Enterprise Value	34	42	45	25	-
Last Close Price	0.45	0.56	0.70	0.50	-
PE Ratio	-	-7.78	-7.05	-5.03	-
PB Ratio	-25.90	-25.90	-624.83	29.09	-
P/FCF Ratio	-12.50	-12.50	-9.78	-7.08	-
P/OCF Ratio	-12.66	-12.66	-9.95	-7.09	-
EV/EBITDA Ratio	-8.03	-8.03	-7.47	-5.36	-
EV/EBIT Ratio	-8.00	-8.00	-7.45	-5.35	-
EV/FCF Ratio	-10.36	-12.65	-9.70	-6.52	-
Debt / Equity Ratio	-0.31	-0.31	-3.35	0.05	0.61
Debt / FCF Ratio	-0.15	-0.15	-0.05	-0.01	-0.23
Quick Ratio	0.01	0.01	0.27	2.86	0.39
Current Ratio	0.03	0.03	0.32	2.93	1.05
Return on Equity (ROE)	-	-	-1370.69%	-857.63%	-
Return on Assets (ROA)	-195.03%	-195.03%	-226.85%	-149.93%	-
Return on Capital (ROIC)	-	-	-644.78%	-474.05%	-
Earnings Yield	-16.00%	-12.70%	-13.33%	-17.24%	-
FCF Yield	-9.79%	-8.00%	-10.23%	-14.13%	-
Buyback Yield / Dilution	-20.37%	-20.37%	-26.29%	-41.35%	-
Total Shareholder Return	-20.37%	-20.37%	-26.29%	-41.35%	-

Source: S&P Capital IQ. Standard template. Financial Sources.